Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-09-12)Premium Content

Sarepta Therapeutics Inc New (SRPT)

2014-11-26@07:10:43 ET
Prosensa Soars on $680M Buyout Offer from BioMarin (ZAX)

2014-11-26@03:56:35 ET
Sarepta Therapeutics initiates dosing in Duchenne muscular dystrophy study (DTM)

2014-11-24@16:30:12 ET
Sarepta Therapeutics to Host Webcast and Conference Call for the Duchenne Muscular Dystrophy Community on December 2, 2014 (BIZ)

2014-11-24@07:00:28 ET
Sarepta Therapeutics to Present Company Overview at Upcoming Conferences (BIZ)

2014-11-21@12:54:11 ET
Sarepta Therapeutics Q3 net loss decreases (DTM)

2014-11-21@00:54:03 ET
Eteplirsen Study Commences (CLM)

2014-11-19@09:31:00 ET
Critical Alerts For SunEdison, Invensense, JinkoSolar, Inovio Pharmaceuticals and Sarepta Therapeutics Released By InvestorsObserver (PRN)

2014-11-18@15:24:00 ET
Robbins Arroyo LLP Is Investigating the Officers and Directors of Sarepta Therapeutics, Inc. (SRPT) on Behalf of Shareholders (PRN)

2014-11-18@09:15:04 ET
Sarepta Therapeutics Announces First Patient Dosed in Confirmatory Study of Eteplirsen in Ambulant Patients with Duchenne Muscular Dystrophy (BIZ)

2014-11-17@05:17:00 ET
Sarepta Therapeutics initiates dosing in Duchenne muscular dystrophy study (DTM)

2014-11-17@02:04:29 ET
Sarepta Therapeutics Reports First Patient Dosed in Study of Eteplirsen (CLM)

2014-11-14@18:16:00 ET
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Sarepta Therapeutics, Inc. (SRPT) To Contact The Firm (PRN)

2014-11-12@17:15:01 ET
Sarepta Therapeutics Announces First Patient Dosed in Study of Eteplirsen in Non-Ambulant Patients with Duchenne Muscular Dystrophy (BIZ)

2014-11-12@05:32:38 ET
Global Ebola Viral Infections Clinical Trials Report H2, 2014 - Commercial Landscape of the Major Companies / Universities / Institutes / Hospitals (MTO)

2014-11-11@10:32:04 ET
INVESTOR ALERT: Investigation of Sarepta Therapeutics, Inc. Announced by Glancy Binkow & Goldberg LLP (BIZ)

2014-11-10@16:14:05 ET
SHAREHOLDER ALERT: Investigation on Behalf of Sarepta Therapeutics, Inc. Investors Announced by Law Offices of Howard G. Smith (BIZ)

2014-11-07@00:51:07 ET
Sarepta Therapeutics to Participate at Upcoming Conferences (CLM)

2014-11-06@07:17:43 ET
8-K: Sarepta Therapeutics, Inc. (EDK)

2014-11-06@07:01:48 ET
Sarepta Therapeutics Announces Third Quarter 2014 Financial Results and Recent Corporate Developments (BIZ)

2014-11-06@06:33:10 ET
10-Q: SAREPTA THERAPEUTICS, INC. (EDG)